Lesions 2 and 5, which had the same histology of adenocarcinomas in situ, harbored the BRAF driver mutation G466E and V600_K601delinsE, respectively, while lesion 6 harbored a BRAF K601E (Table 1, Additional file 3). This evidence concerns the gene BRAF and adenocarcinoma in situ.